Clinical management of amyloid cardiomyopathy

Morris M. Kim, Clinton M. Kolseth, Dayna Carlson, Ahmad Masri

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Clinical heart failure, restrictive cardiomyopathy, and arrhythmias are hallmark features of amyloid cardiomyopathy. In contrast to the advancements in targeted therapies, there is a general lack of evidence-based practice guidelines for clinical management of amyloid cardiomyopathy. In this review, we review the role of routine medical therapy in amyloid cardiomyopathy, from heart failure management to orthostatic hypotension, atrial arrhythmias, thromboembolic complications, and prevention of sudden death. We conclude by discussing approaches to patients with end-stage disease.

Original languageEnglish (US)
Pages (from-to)1549-1557
Number of pages9
JournalHeart Failure Reviews
Issue number5
StatePublished - Sep 2022


  • Amyloidosis
  • Atrial fibrillation
  • Heart failure
  • Orthostatic hypotension
  • Restrictive cardiomyopathy
  • Sudden cardiac death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Clinical management of amyloid cardiomyopathy'. Together they form a unique fingerprint.

Cite this